Entrada Therapeutics Inc.
TRDA | NASDAQ
$6.78
+$0.14 (+2.11%)
Sep 22, 2026, 1:36 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -42.76M | -39.72M | -39.16M | -44.13M | -43.1M | -17.35M | 1.13M | -14.03M | 55.03M | 23.5M | -9.54M | 35.46M | -25.93M | -6.67M | -24.63M | -25.14M | -23.18M | -21.67M | -18.45M | -14.43M | -9.9M | -8.38M |
Depreciation & Amortization | 1.65M | 805K | -2.79M | 1.23M | 1.03M | 946K | 992K | 937K | 910K | 934K | 736K | 834K | 730K | 541K | 525K | 516K | 463K | 390K | 364K | 302K | 252K | 199K |
Stock-Based Compensation | 9.89M | 4.74M | 4.36M | 5.12M | 5.05M | 5.09M | 4.7M | 4.86M | 4.62M | 3.73M | 3.84M | 3.4M | 3.12M | 2.76M | 2.88M | 2.71M | 2.51M | 1.79M | 1.46M | 578K | 326K | 164K |
Other Working Capital | -2.22M | -8.01M | 3.21M | 8.92M | 7.95M | -25.58M | -37.69M | -17.58M | -87.42M | 20.65M | 1.4M | -59.69M | -9.49M | 206.48M | -10.57M | -2.63M | 510K | -3.71M | -2.81M | -758K | 914K | -51K |
Other Non-Cash Items | -2.67M | -548K | 3.04M | -739K | -961K | -1.34M | -2.51M | -3.21M | -2.26M | -2.04M | -2M | -1.85M | -1.69M | -237K | -103K | -32K | 145K | 142K | -79K | 153K | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.79M | -6.98M | 2.35M | 10.21M | 8.49M | -25.85M | -35.92M | -12.82M | -18.47M | -51.65M | 2.95M | -62.33M | -11.32M | 207.01M | -5.98M | -5.54M | 2.05M | -1.65M | -3.84M | -678K | 1.41M | -319K |
Operating Cash Flow | -35.69M | -41.7M | -32.2M | -28.31M | -29.49M | -38.51M | -31.61M | -24.27M | 39.83M | -25.52M | -4.01M | -24.49M | -35.09M | 203.4M | -27.3M | -27.48M | -18.01M | -20.99M | -20.54M | -14.08M | -7.91M | -8.34M |
Capital Expenditures | -11K | -44K | 207K | 171K | -275K | -1.14M | -635K | -639K | -1.05M | -838K | -976K | -1.45M | -1.52M | -1.67M | -708K | -810K | -775K | -594K | -1.32M | -806K | -1.54M | -908K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -15.75M | -11.83M | -18.47M | -26.57M | -16.55M | -80.02M | -64.5M | -165.59M | -110.69M | -96.94M | -88.52M | -76.79M | -140.12M | -101.78M | n/a | -39.32M | n/a | -182.65M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 58.89M | 38.86M | 47.39M | 75.5M | 50.63M | 85.95M | 118.5M | 83.31M | 87.36M | 123.92M | 108.54M | 74.5M | 28.39M | 63M | 19.5M | 30M | 25M | 1.71M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 43.12M | 26.99M | 29.12M | 49.11M | 33.8M | 4.78M | 53.37M | -82.93M | -24.38M | 26.15M | 19.04M | -3.74M | -113.26M | -40.44M | 18.79M | -10.13M | 24.23M | -181.53M | -1.32M | -806K | -1.54M | -908K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 320K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 350K | n/a | n/a | n/a | n/a | n/a | n/a | 381K | 1.37M | n/a | n/a | n/a | n/a | 129K | n/a | n/a | n/a | n/a | n/a | n/a | 632K | 137K |
Financial Cash Flow | 570K | 100K | 192K | 8K | 337K | 350K | 1.4M | -11K | 101.37M | 206K | 690K | 368K | 443K | 19.54M | 358K | 60K | 11K | 50K | 190.76M | 106K | 215K | 116.39M |
Net Cash Flow | 8.01M | -14.61M | -2.89M | 20.8M | 4.65M | -33.37M | 23.16M | -107.2M | 116.82M | 834K | 15.72M | -27.86M | -147.91M | 182.49M | -8.15M | -37.56M | 6.23M | -202.47M | 168.89M | -14.78M | -9.24M | 107.14M |
Free Cash Flow | -35.7M | -41.74M | -32M | -28.14M | -29.76M | -39.65M | -32.24M | -24.91M | 38.79M | -26.36M | -4.99M | -25.94M | -36.61M | 201.73M | -28.01M | -28.29M | -18.78M | -21.59M | -21.86M | -14.88M | -9.45M | -9.24M |
Adj. Free Cash Flow | -45.59M | -46.48M | -36.35M | -33.26M | -34.81M | -44.74M | -36.94M | -29.77M | 34.17M | -30.09M | -8.83M | -29.34M | -39.73M | 198.98M | -30.89M | -31M | -21.3M | -23.38M | -23.32M | -15.46M | -9.78M | -9.41M |
Maintenance CapEx | -11K | -44K | 207K | 171K | -275K | -1.14M | -635K | -639K | n/a | n/a | n/a | n/a | n/a | n/a | -525K | -516K | -463K | -390K | -364K | -302K | -252K | -199K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.05M | -838K | -976K | -1.45M | -1.52M | -1.67M | -183K | -294K | -312K | -204K | -958K | -504K | -1.29M | -709K |
Owner Earnings | -35.7M | -41.74M | -32M | -28.14M | -29.76M | -39.65M | -32.24M | -24.91M | 39.83M | -25.52M | -4.01M | -24.49M | -35.09M | 203.4M | -27.83M | -28M | -18.47M | -21.38M | -20.91M | -14.38M | -8.16M | -8.54M |
Add to Watchlist
Select watchlists to add or remove TRDA